Clinical Data

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Endometrial cancer data on Genmab’s Elahere rival beat forecast

The biotech reported a 50% unconfirmed response rate, beating the expectations of analysts to boost confidence ahead of a move into phase 3.
Nick Paul Taylor May 23, 2025 9:22am
Businessman climbing steps to pluck a star from the sky

Merus hails 'unprecedented' survival on solid tumor bispecific

May 23, 2025 7:35am
graphic image of a cube with an arrow nailing the bullseye

ASCO: Cullinan drug sees 35% ORR in pretreated NSCLC

May 22, 2025 5:00pm
Lungs illustration Image Pixabay

Boehringer's phase 3 lung data get muted response from analysts

May 19, 2025 9:24am
gene therapy AAV adeno-associated viruses

Neurogene details death in Rett syndrome gene therapy trial

May 16, 2025 3:00pm
An arrow incrementally going up stairs before pointing straight up Blue background

Leo's eczema prospect hits primary endpoint in phase 2b

May 9, 2025 7:30am